ブレインコンピュータインターフェース (BCI)の世界市場:製品別(侵襲式、部分的侵襲式、非侵襲式)、用途別(ヘルスケア、コミュニケーションおよび制御)、最終用途別

◆英語タイトル:Brain Computer Interface Market Size, Share & Trends Analysis Report By Product (Invasive, Partially Invasive, Non-invasive), By Application (Healthcare, Communication & Control), By End Use, And Segment Forecasts, 2020 - 2027
◆商品コード:GV20MY037
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2020年3月4日
◆ページ数:120
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥624,750見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥729,750見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥939,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、ブレインコンピュータインターフェース (BCI)の世界市場について調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場要因・動向・範囲、製品別(侵襲式、部分的侵襲式、非侵襲式)分析、用途別(ヘルスケア、コミュニケーションおよび制御、スマートホームコントロール、エンターテイメント&ゲーム)分析、最終用途別(医療、軍事、その他)分析、地域別分析、企業概要などの構成でお届けいたします。
・調査手法・範囲
・エグゼクティブサマリー
・市場要因・動向・範囲
・ブレインコンピュータインターフェース (BCI)の世界市場:製品別(侵襲式、部分的侵襲式、非侵襲式)
・ブレインコンピュータインターフェース (BCI)の世界市場:用途別(ヘルスケア、コミュニケーションおよび制御、スマートホームコントロール、エンターテイメント&ゲーム)
・ブレインコンピュータインターフェース (BCI)の世界市場:最終用途別(医療、軍事、その他)
・ブレインコンピュータインターフェース (BCI)の世界市場:地域別
・企業概要
【レポートの概要】

The global brain computer interface market size is expected to reach USD 3.7 billion by 2027, according to a new report by Grand View Research, Inc., registering a CAGR of 15.5% over the forecast period. Brain computer interface (BCI) is a revolutionary technology that facilitates direct contact between peripheral electronic devices calibrating the movement and a functional brain in physically challenged people. A BCI records the brain signal from the sensors that are placed on the scalp or devices implanted in brain.

The market growth is driven by continuous developments in medical sensors and computational biology. In addition, increasing R&D for advancements in treatment options for chronic conditions such as cerebrovascular diseases, sleep disorders, brain disorders, and fatal injuries contributes to the significant growth rate of the market. Rising number of government projects such as DECODER, a European project that uses brain computer interface to detect consciousness in non-responsive patients, is also expected to positively influence market growth. Moreover, several major market players focus on expanding their presence in emerging economies such as Japan and China, which would drive the overall market growth over the forecast period.

Ongoing technological advancements in the field of virtual reality and increasing applications of BCI in the communications, gaming, and entertainment industries are some of the key contributors driving the market for brain computer interface technology. BCI technology encompasses a wide range of applications designed to revolutionize the communication, automation, security, and entertainment experience. BCI is an emerging technology which is currently at a nascent stage. However, increasing interest among researchers and their collaboration with governments is expected to drive the demand for BCI technology.

North America dominated the market in 2019 owing to a large number of clinical trials conducted in the region. In addition, rising incidences of neurodegenerative conditions such as Parkinson’s, Alzheimer’s, and Huntington’s disease in this region are expected to drive the market growth. In addition, rising demand for immersive gaming, which adopts technologies such as BCI, is also expected to drive the regional market growth.

Further key findings from the report suggest:

• The non-invasive segment dominated the BCI market in 2019. Technological advancements and increasing popularity of gaming and entertainment act as key growth contributors for this segment

• On the basis of application, healthcare was the largest revenue generating segment in 2019. Increasing application of BCI technology for the treatment of sleeping disorders, Alzheimer’s disease, and Parkinson’s disease is a key factor contributing to the growth of the segment

• The military segment is expected to show lucrative growth over the forecast period owing to the increased application of BCI technology in war zones

• Asia Pacific is expected to exhibit the highest growth rate over the forecast period. Increasing disposable income and low-cost manufacturing sites are expected to drive the market growth in the coming years

• Some of the key companies present in the brain computer interface market are Neurosky, Compudemics, Natus Medical, Mind Solutions, and Advanced Brain Monitoring.

【レポートの目次】

Table of Contents

Chapter 1 Research Methodology & Scope
1.1 Market Segmentation & Scope
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database:
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details of Primary Research
1.3.5.1 Data for primary interviews in North America
1.3.5.2 Data for primary interviews in Europe
1.3.5.3 Data for primary interviews in Asia Pacific
1.3.5.4 Data for primary interviews in Middle East and Africa
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 Report Objectives
Chapter 2 Executive Summary
2.1 Market Outlook
2.1.1 Brain Computer Interface Market Outlook, 2016 – 2027 (USD Million)
2.2 Brain Computer Interface Market Summary, 2019
Chapter 3 Brain Computer Interface Market Variables, Trends & Scope
3.1 Penetration & Growth Prospect Mapping
3.2 User Perspective Analysis
3.2.1 Market Influencer Analysis
3.3 Brain Computer Interface Market Dynamics
3.3.1 Market Driver Analysis
3.3.1.1 Increasing prevalence of neurodegenerative disorders
3.3.1.2 Increasing global geriatric population
3.3.1.3 Increasing demand for virtual gaming experience and home control systems
3.3.1.4 Increasing R&D spending over military and medical applications
3.3.2 Market Restraint Analysis
3.3.2.1 Adverse usage of technology
3.3.2.2 Rising public concern about ethical issues associated with brain computer interface
3.4 Brain Computer Interface Market Analysis Tools: Porter’s Analysis
3.4.1 Supplier Power: High
3.4.2 Buyer Power: Moderate
3.4.3 Threat Of Substitutes: High
3.4.4 Threat Of New Entrants: Moderate to Low
3.4.5 Competitive Rivalry: Moderate
3.5 PESTEL Analysis
3.5.1 Political/Legal Landscape
3.5.2 Economic Landscape
3.5.3 Technology Landscape
3.6 Market Participation Categorization
3.6.1 Competitive Dashboard Analysis
3.7 Major Deals & Strategic Alliances Analysis
3.8 Public Companies
3.9 Private Companies
Chapter 4 Brain Computer Interface Market: Product Estimates & Trend Analysis
4.1 Product Market Share Analysis, 2019 & 2027
4.2 Product Dashboard
4.2.1 Invasive Brain-Computer Interface
4.2.1.1 Invasive Brain-Computer Interface market estimates and forecasts, 2016 – 2027 (USD Million)
4.2.2 Partially Invasive Brain-Computer Interface
4.2.2.1 Partially invasive brain-computer interface market estimates and forecasts, 2016 – 2027 (USD Million)
4.2.3 Non-invasive Brain-Computer Interface
4.2.3.1 Noninvasive brain-computer interface market estimates and forecasts, 2016 – 2027 (USD Million)
Chapter 5 Brain Computer Interface Market: Application Estimates & Trend Analysis
5.1 Application Market Share Analysis, 2019 & 2027
5.2 Application Dashboard
5.3 Healthcare
5.3.1 Healthcare Market Estimates And Forecasts, 2016 – 2027 (USD Million)
5.3.2 Disabilities Restoration Market Estimates And Forecasts, 2016 – 2027 (USD Million)
5.3.3 Brain Function Repair Market Estimates And Forecasts, 2016 – 2027 (USD Million)
5.4 Smart home control
5.4.1 Smart Home Control Market Estimates And Forecasts, 2016 – 2027 (USD Million)
5.5 Communication and control
5.5.1 Communication And Control Market Estimates And Forecasts, 2016 – 2027 (USD Million)
5.6 Entertainment & Gaming
5.6.1 Entertainment & Gaming Market Estimates And Forecasts, 2016 – 2027 (USD Million)
Chapter 6 Brain Computer Interface Market: End use Estimates & Trend Analysis
6.1 End use Market Share Analysis, 2019 & 2027
6.2 End use Dashboard
6.3 Medical
6.3.1 Medical Market Estimates And Forecasts, 2016 – 2027 (USD Million)
6.4 Military
6.4.1 Military Market Estimates And Forecasts, 2016 – 2027 (USD Million)
6.5 Others
6.5.1 Others Market Estimates And Forecasts, 2016 – 2027 (USD Million)
Chapter 7 Brain Computer Interface Market: Regional Estimates & Trend Analysis, By Product, Application, And End-Use
7.1 Regional Market Snapshot
7.2 North America
7.2.1 North America Brain Computer Interface Market Estimates And Forecasts, 2016 – 2027 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S. Brain Computer Interface market estimates and forecasts, 2016 – 2027 (USD Million)
7.2.3 Canada
7.2.3.1 Canada Brain Computer Interface market estimates and forecasts, 2016 – 2027 (USD Million)
7.3 Europe
7.3.1 Europe Brain Computer Interface Market Estimates And Forecasts, 2016 – 2027 (USD Million)
7.3.2 U.K.
7.3.2.1 U.K. Brain Computer Interface market estimates and forecasts, 2016 – 2027 (USD Million)
7.3.3 Germany
7.3.3.1 Germany Brain Computer Interface market estimates and forecasts, 2016 – 2027 (USD Million)
7.3.4 Spain
7.3.4.1 Spain Brain Computer Interface market estimates and forecasts, 2016 – 2027 (USD Million)
7.3.5 France
7.3.5.1 France Brain Computer Interface market estimates and forecasts, 2016 – 2027 (USD Million)
7.3.6 Italy
7.3.6.1 Italy Brain Computer Interface market estimates and forecasts, 2016 – 2027 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific Brain Computer Interface Market Estimates And Forecasts, 2016 – 2027 (USD Million)
7.4.2 Japan
7.4.2.1 Japan Brain Computer Interface market estimates and forecasts, 2016 – 2027 (USD Million)
7.4.3 China
7.4.3.1 China Brain Computer Interface market estimates and forecasts, 2016 – 2027 (USD Million)
7.4.4 India
7.4.4.1 India Brain Computer Interface market estimates and forecasts, 2016 – 2027 (USD Million)
7.5 Latin America
7.5.1 Latin America Brain Computer Interface Market Estimates And Forecasts, 2016 – 2027 (USD Million)
7.5.2 Mexico
7.5.2.1 Mexico Brain Computer Interface market estimates and forecasts, 2016 – 2027 (USD Million)
7.5.3 Brazil
7.5.3.1 Brazil Brain Computer Interface market estimates and forecasts, 2016 – 2027 (USD Million)
7.6 MEA
7.6.1 MEA Brain Computer Interface Market Estimates And Forecasts, 2016 – 2027 (USD Million)
7.6.2 South Africa
7.6.2.1 South Africa Brain Computer Interface market estimates and forecasts, 2016 – 2027 (USD Million)
7.6.3 Saudi Arabia
7.6.3.1 Saudi Arabia Brain Computer Interface market estimates and forecasts, 2016 – 2027 (USD Million)
Chapter 8 Company Profiles
8.1 Natus Medical Incorporated
8.1.1 Company Overview
8.1.2 Financial Performance
8.1.3 Product Benchmarking
8.1.4 Strategic Initiatives
8.2 Guger Technologies Og
8.2.1 Company Overview
8.2.2 Financial Performance
8.2.3 Product Benchmarking
8.3 Mind Solutions Corporation
8.3.1 Company Overview
8.3.2 Financial Performance
8.3.3 Product Benchmarking
8.3.4 Strategic Initiatives
8.4 Medtronic
8.4.1 Company Overview
8.4.2 Financial Performance
8.4.3 Product Benchmarking
8.4.4 Strategic Initiatives
8.5 Compumedics Ltd.
8.5.1 Company Overview
8.5.2 Financial Performance
8.5.3 Product Benchmarking
8.5.4 Strategic Initiatives
8.6 Interactive Productline
8.6.1 Company Overview
8.6.2 Financial Performance
8.6.3 Product Benchmarking
8.7 Integra Lifesciences Corporation
8.7.1 Company Overview
8.7.2 Financial Performance
8.7.3 Product Benchmarking
8.7.4 Strategic Initiatives
8.8 Advanced Brain Monitoring, Inc.
8.8.1 Company Overview
8.8.2 Financial Performance
8.8.3 Product Benchmarking
8.8.4 Strategic Initiatives
8.9 Emotiv Incorporation
8.9.1 Company Overview
8.9.2 Financial Performance
8.9.3 Product Benchmarking
8.10 Neurosky
8.10.1 Company Overview
8.10.2 Financial Performance
8.10.3 Product Benchmarking
8.10.4 Strategic Initiatives
8.11 Iwinks
8.11.1 Company Overview
8.11.2 Financial Performance
8.11.3 Product Benchmarking
8.11.4 Strategic Initiatives
8.12 Interaxon
8.12.1 Company Overview
8.12.2 Financial Performance
8.12.3 Product Benchmarking
8.12.4 Strategic Initiatives
8.13 Ant Neuro
8.13.1 Company Overview
8.13.2 Financial Performance
8.13.3 Product Benchmarking
8.13.4 Strategic Initiatives
8.14 Neuroelectrics
8.14.1 Company Overview
8.14.2 Financial Performance
8.14.3 Product Benchmarking
8.14.4 Strategic Initiatives
8.15 Ripple
8.15.1 Company Overview
8.15.2 Financial Performance
8.15.3 Product Benchmarking
8.15.4 Strategic Initiatives
8.16 Puzzlebox
8.16.1 Company Overview
8.16.2 Financial Performance
8.16.3 Product Benchmarking
8.16.4 Strategic Initiatives
8.17 Nirx Medical Technologies
8.17.1 Company Overview
8.17.2 Financial Performance
8.17.3 Product Benchmarking
8.17.4 Strategic Initiatives
8.18 Nielsen Holding
8.18.1 Company Overview
8.18.2 Financial Performance
8.18.3 Product Benchmarking
8.18.4 Strategic Initiatives
8.19 Brain Products GmbH
8.19.1 Company Overview
8.19.2 Financial Performance
8.19.3 Product Benchmarking
8.19.4 Strategic Initiatives
8.20 Cerora Incorporation
8.20.1 Company Overview
8.20.2 Financial Performance
8.20.3 Product Benchmarking
8.21 Cognionics
8.21.1 Company Overview
8.21.2 Financial Performance
8.21.3 Product Benchmarking
8.21.4 Strategic Initiatives

List of Tables

Table 1 List of Abbreviation
Table 2 North America controlled release drug delivery market, by region, 2016 - 2027 (USD Million)
Table 3 North America controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
Table 4 North America controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
Table 5 North America controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
Table 6 U.S. controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
Table 7 U.S. controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
Table 8 U.S. controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
Table 9 Canada controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
Table 10 Canada controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
Table 11 Canada controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
Table 12 Europe controlled release drug delivery market, by region, 2016 - 2027 (USD Million)
Table 13 Europe controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
Table 14 Europe controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
Table 15 Europe controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
Table 16 Germany controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
Table 17 Germany controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
Table 18 Germany controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
Table 19 U.K. controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
Table 20 U.K. controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
Table 21 U.K. controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
Table 22 France controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
Table 23 France controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
Table 24 France controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
Table 25 Italy controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
Table 26 Italy controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
Table 27 Italy controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
Table 28 Spain controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
Table 29 Spain controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
Table 30 Spain controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
Table 31 The Netherland controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
Table 32 The Netherland controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
Table 33 The Netherland controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
Table 34 Switzerland controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
Table 35 Switzerland controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
Table 36 Switzerland controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
Table 37 Russia controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
Table 38 Russia controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
Table 39 Russia controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
Table 40 Sweden controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
Table 41 Sweden controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
Table 42 Sweden controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
Table 43 Belgium controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
Table 44 Belgium controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
Table 45 Belgium controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
Table 46 Asia Pacific controlled release drug delivery market, by region, 2016 - 2027 (USD Million)
Table 47 Asia Pacific controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
Table 48 Asia Pacific controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
Table 49 Asia Pacific controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
Table 50 Japan controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
Table 51 Japan controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
Table 52 Japan controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
Table 53 China controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
Table 54 China controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
Table 55 China controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
Table 56 India controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
Table 57 India controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
Table 58 India controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
Table 59 South Korea controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
Table 60 South Korea controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
Table 61 South Korea controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
Table 62 Thailand controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
Table 63 Thailand controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
Table 64 Thailand controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
Table 65 Indonesia controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
Table 66 Indonesia controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
Table 67 Indonesia controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
Table 68 Philippines controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
Table 69 Philippines controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
Table 70 Philippines controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
Table 71 Vietnam controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
Table 72 Vietnam controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
Table 73 Vietnam controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
Table 74 Singapore controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
Table 75 Singapore controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
Table 76 Singapore controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
Table 77 Malaysia controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
Table 78 Malaysia controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
Table 79 Malaysia controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
Table 80 Latin America controlled release drug delivery market, by region, 2016 - 2027 (USD Million)
Table 81 Latin America controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
Table 82 Latin America controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
Table 83 Latin America controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
Table 84 Brazil controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
Table 85 Brazil controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
Table 86 Brazil controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
Table 87 Mexico controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
Table 88 Mexico controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
Table 89 Mexico controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
Table 90 Argentina controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
Table 91 Argentina controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
Table 92 Argentina controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
Table 93 Colombia controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
Table 94 Colombia controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
Table 95 Colombia controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
Table 96 Chile controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
Table 97 Chile controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
Table 98 Chile controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
Table 99 Middle east and Africa controlled release drug delivery market, by region, 2016 - 2027 (USD Million)
Table 100 Middle east and Africa controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
Table 101 Middle east and Africa controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
Table 102 Middle east and Africa controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
Table 103 South Africa controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
Table 104 South Africa controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
Table 105 South Africa controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
Table 106 Saudi Arabia controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
Table 107 Saudi Arabia controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
Table 108 Saudi Arabia controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
Table 109 UAE controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
Table 110 UAE controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
Table 111 UAE controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
Table 112 Kuwait controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
Table 113 Kuwait controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
Table 114 Kuwait controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
Table 115 Israel controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
Table 116 Israel controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
Table 117 Israel controlled release drug delivery market, by application, 2016 - 2027 (USD Million)


List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 controlled release drug delivery market: market outlook
Fig. 14 controlled release drug delivery market competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 controlled release drug delivery market driver impact
Fig. 20 controlled release drug delivery market restraint impact
Fig. 21 controlled release drug delivery market strategic initiatives analysis
Fig. 22 controlled release drug delivery market: technology movement analysis
Fig. 23 controlled release drug delivery market: technology outlook and key takeaways
Fig. 24 Wurster technique market estimates and forecast, 2016 - 2027
Fig. 25 Coacervation market estimates and forecast, 2016 - 2027
Fig. 26 Micro encapsulation market estimates and forecast, 2016 - 2027
Fig. 27 Implants market estimates and forecast, 2016 - 2027
Fig. 28 Transdermal market estimates and forecast, 2016 - 2027
Fig. 29 Targeted delivery market estimates and forecast, 2016 - 2027
Fig. 30 Others market estimates and forecast, 2016 - 2027
Fig. 31 controlled release drug delivery market: release mechanism movement analysis
Fig. 32 controlled release drug delivery market: release mechanism outlook and key takeaways
Fig. 33 Polymer based systems market estimates and forecast, 2016 - 2027
Fig. 34 Micro reservoir partition-controlled drug delivery systems estimates and forecasts, 2016 - 2027
Fig. 35 Feedback regulate drug delivery systems estimates and forecasts, 2016 - 2027
Fig. 36 Activation-modulated drug delivery systems estimates and forecasts, 2016 - 2027
Fig. 37 Chemically activated drug delivery systems estimates and forecasts, 2016 - 2027
Fig. 38 controlled release drug delivery market: application movement analysis
Fig. 39 controlled release drug delivery market: application outlook and key takeaways
Fig. 40 Metered dose inhaler market estimates and forecasts, 2016 - 2027
Fig. 41 Injectable controlled release drug delivery market estimates and forecasts, 2016 - 2027
Fig. 42 Transdermal and Ocular patches controlled release drug delivery market estimates and forecasts, 2016 - 2027
Fig. 43 Infusion pumps controlled release drug delivery market estimates and forecasts, 2016 - 2027
Fig. 44 Oral controlled drug delivery systems market estimates and forecasts, 2016 - 2027
Fig. 45 Drug eluting stents controlled release drug delivery market estimates and forecasts, 2016 - 2027
Fig. 46 Global controlled release drug delivery market: regional movement analysis
Fig. 47 Global controlled release drug delivery market: regional outlook and key takeaways
Fig. 48 Global controlled release drug delivery market share and leading players
Fig. 49 North America market share and leading players
Fig. 50 Europe market share and leading players
Fig. 51 Asia Pacific market share and leading players
Fig. 52 Latin America market share and leading players
Fig. 53 Middle East & Africa market share and leading players
Fig. 54 North America: SWOT
Fig. 55 Europe SWOT
Fig. 56 Asia Pacific SWOT
Fig. 57 Latin America SWOT
Fig. 58 MEA SWOT
Fig. 59 North America, by country
Fig. 60 North America
Fig. 61 North America market estimates and forecasts, 2016 - 2027
Fig. 62 U.S.
Fig. 63 U.S. market estimates and forecasts, 2016 - 2027
Fig. 64 Canada
Fig. 65 Canada market estimates and forecasts, 2016 - 2027
Fig. 66 Europe
Fig. 67 Europe. market estimates and forecasts, 2016 - 2027
Fig. 68 U.K.
Fig. 69 U.K. market estimates and forecasts, 2016 - 2027
Fig. 70 Germany
Fig. 71 Germany market estimates and forecasts, 2016 - 2027
Fig. 72 France
Fig. 73 France market estimates and forecasts, 2016 - 2027
Fig. 74 Italy
Fig. 75 Italy market estimates and forecasts, 2016 - 2027
Fig. 76 Spain
Fig. 77 Spain market estimates and forecasts, 2016 - 2027
Fig. 78 Russia
Fig. 79 Russia market estimates and forecasts, 2016 - 2027
Fig. 80 The Netherlands
Fig. 81 The Netherlands market estimates and forecasts, 2016 - 2027
Fig. 82 Switzerland
Fig. 83 Switzerland market estimates and forecasts, 2016 - 2027
Fig. 84 Sweden
Fig. 85 Sweden market estimates and forecasts, 2016 - 2027
Fig. 86 Belgium
Fig. 87 Belgium market estimates and forecasts, 2016 - 2027
Fig. 88 Asia Pacific
Fig. 89 Asia Pacific market estimates and forecasts, 2016 - 2027
Fig. 90 China
Fig. 91 China market estimates and forecasts, 2016 - 2027
Fig. 92 Japan
Fig. 93 Japan market estimates and forecasts, 2016 - 2027
Fig. 94 India
Fig. 95 India market estimates and forecasts, 2016 - 2027
Fig. 96 Thailand
Fig. 97 Thailand. market estimates and forecasts, 2016 - 2027
Fig. 98 South Korea
Fig. 99 South Korea market estimates and forecasts, 2016 - 2027
Fig. 100 Indonesia
Fig. 101 Indonesia market estimates and forecasts, 2016 - 2027
Fig. 102 Philippines
Fig. 103 Philippines market estimates and forecasts, 2016 - 2027
Fig. 104 Vietnam
Fig. 105 Vietnam market estimates and forecasts, 2016 - 2027
Fig. 106 Singapore
Fig. 107 Singapore market estimates and forecasts, 2016 - 2027
Fig. 108 Malaysia
Fig. 109 Malaysia market estimates and forecasts, 2016 - 2027
Fig. 110 Latin America
Fig. 111 Latin America market estimates and forecasts, 2016 - 2027
Fig. 112 Brazil
Fig. 113 Brazil market estimates and forecasts, 2016 - 2027
Fig. 114 Mexico
Fig. 115 Mexico market estimates and forecasts, 2016 - 2027
Fig. 116 Argentina
Fig. 117 Argentina market estimates and forecasts, 2016 - 2027
Fig. 118 Colombia
Fig. 119 Colombia market estimates and forecasts, 2016 - 2027
Fig. 120 Chile
Fig. 121 Chile market estimates and forecasts, 2016 - 2027
Fig. 122 Middle East and Africa
Fig. 123 Middle East and Africa. market estimates and forecasts, 2016 - 2027
Fig. 124 South Africa
Fig. 125 South Africa market estimates and forecasts, 2016 - 2027
Fig. 126 Saudi Arabia
Fig. 127 Saudi Arabia market estimates and forecasts, 2016 - 2027
Fig. 128 UAE
Fig. 129 UAE market estimates and forecasts, 2016 - 2027
Fig. 130 Kuwait
Fig. 131 Kuwait market estimates and forecasts, 2016 - 2027
Fig. 132 Israel
Fig. 133 Israel market estimates and forecasts, 2016 - 2027
Fig. 134 Participant categorization- controlled release drug delivery market
Fig. 135 Market share of key market players- controlled release drug delivery market

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[ブレインコンピュータインターフェース (BCI)の世界市場:製品別(侵襲式、部分的侵襲式、非侵襲式)、用途別(ヘルスケア、コミュニケーションおよび制御)、最終用途別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆